Mercia makes follow-on investment in fast growth biotech

Mark Payton, CEO of Mercia Technologies
Specialist funder Mercia Technologies has completed a £2m follow-up investment into one of its portfolio businesses. The Warwickshire funder, focused on innovative technology businesses with high growth potential, has ploughed the money into Oxford Genetics, a synthetic biology company helping to design, develop and produce virus and protein-based biologics to support leading therapeutic companies. This investment is part of a £7.5m funding round which also sees a new investor, Invesco Asset Management joining the syndication ... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...